Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
ACRES Commercial Realty Corp. price target raised to $18 from $13.50 at Raymond James » 07:25
03/16/21
03/16
07:25
03/16/21
07:25
ACR

ACRES Commercial Realty Corp.

$15.89 /

-0.02 (-0.13%)

Raymond James analyst…

Raymond James analyst Stephen Laws raised the firm's price target on ACRES Commercial Realty Corp. to $18 from $13.50. The analyst keeps an Outperform rating on the shares owing to attractive risk-reward dynamic given the improving portfolio performance, outlook for new investments, and expectation of a dividend reinstatement in Q1, Laws tells investors in a research note.

ShowHide Related Items >><<
ACR ACRES Commercial Realty Corp.
$15.89 /

-0.02 (-0.13%)

ACR ACRES Commercial Realty Corp.
$15.89 /

-0.02 (-0.13%)

Options
Five new option listings and two option delistings on February 17th » 08:30
02/17/21
02/17
08:30
02/17/21
08:30
ACR

ACRES Commercial Realty Corp.

$4.35 /

+0.31 (+7.67%)

, CMLF

CM Life Sciences

$24.51 /

-1.26 (-4.89%)

, PACK

Ranpak Holdings

$19.29 /

-0.335 (-1.71%)

, TNL

Travel + Leisure

$51.75 /

-0.04 (-0.08%)

, VISL

Vislink

$4.37 /

+0.3 (+7.37%)

, WYND

Wyndham Destinations

/

+

, XAN

Exantas Capital

/

+

New option listings for…

New option listings for February 17th include ACRES Commercial Realty Corp (ACR), CM Life Sciences Inc (Class A Stock) (CMLF), Ranpak Holdings Corp (Class A Stock) (PACK), Travel plus Leisure Co (TNL), and Vislink Technologies Inc (VISL). Option delistings effective February 17th include Wyndham Destinations Inc (WYND) and Exantas Capital Corp (XAN).

ShowHide Related Items >><<
XAN Exantas Capital
/

+

WYND Wyndham Destinations
/

+

VISL Vislink
$4.37 /

+0.3 (+7.37%)

PACK Ranpak Holdings
$19.29 /

-0.335 (-1.71%)

CMLF CM Life Sciences
$24.51 /

-1.26 (-4.89%)

ACR ACRES Commercial Realty Corp.
$4.35 /

+0.31 (+7.67%)

ACR ACRES Commercial Realty Corp.
$4.35 /

+0.31 (+7.67%)

CMLF CM Life Sciences
$24.51 /

-1.26 (-4.89%)

PACK Ranpak Holdings
$19.29 /

-0.335 (-1.71%)

TNL Travel + Leisure
$51.75 /

-0.04 (-0.08%)

VISL Vislink
$4.37 /

+0.3 (+7.37%)

WYND Wyndham Destinations
/

+

01/12/21 JPMorgan
Wyndham Destinations price target raised to $54 from $49 at JPMorgan
01/06/21 Deutsche Bank
Wyndham Destinations price target raised to $63 from $41 at Deutsche Bank
10/29/20 Deutsche Bank
Wyndham Destinations price target raised to $41 from $38 at Deutsche Bank
10/13/20 JPMorgan
Wyndham Destinations price target raised to $40 from $32 at JPMorgan
XAN Exantas Capital
/

+

11/20/20 Raymond James
Exantas Capital upgraded to Outperform from Market Perform at Raymond James
11/20/20 Raymond James
Exantas Capital upgraded to Outperform from Market Perform at Raymond James
04/13/20 Raymond James
Exantas Capital downgraded to Market Perform from Outperform at Raymond James
04/13/20 Raymond James
Exantas Capital downgraded to Market Perform from Outperform at Raymond James
XAN Exantas Capital
/

+

WYND Wyndham Destinations
/

+

CMLF CM Life Sciences
$24.51 /

-1.26 (-4.89%)

Hot Stocks
ACRES Commercial Realty Corp. finalizes name change » 16:26
02/16/21
02/16
16:26
02/16/21
16:26
ACR

ACRES Commercial Realty Corp.

$0.00 /

+ (+0.00%)

, XAN

Exantas Capital

$4.35 /

+0.31 (+7.67%)

ACRES Commercial Realty…

ACRES Commercial Realty Corp. announced that its name change from "Exantas Capital Corp." is effective. As of tomorrow, February 17, its common shares will trade on the New York Stock Exchange under the symbol "ACR" and its 8.625% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock will trade under the symbol "ACR PrC." The new CUSIP number for the company's common stock is 00489Q102, and the new CUSIP number for its preferred stock is 00489Q201. No action is required by existing shareholders with respect to the name change.

ShowHide Related Items >><<
XAN Exantas Capital
$4.35 /

+0.31 (+7.67%)

ACR ACRES Commercial Realty Corp.
$0.00 /

+ (+0.00%)

XAN Exantas Capital
$4.35 /

+0.31 (+7.67%)

11/20/20 Raymond James
Exantas Capital upgraded to Outperform from Market Perform at Raymond James
11/20/20 Raymond James
Exantas Capital upgraded to Outperform from Market Perform at Raymond James
04/13/20 Raymond James
Exantas Capital downgraded to Market Perform from Outperform at Raymond James
04/13/20 Raymond James
Exantas Capital downgraded to Market Perform from Outperform at Raymond James
XAN Exantas Capital
$4.35 /

+0.31 (+7.67%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.